At a glance
- Originator Yamanouchi
- Class Antifungals; Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycoses
Most Recent Events
- 15 Oct 1998 No-Development-Reported for Mycoses in Japan (Unknown route)
- 02 Oct 1996 New profile
- 02 Oct 1996 Preclinical development for Mycoses in Japan (Unknown route)